ATE335499T1 - Zusammensetzungen zur behandlung von staphylococcus aureus infektionen - Google Patents

Zusammensetzungen zur behandlung von staphylococcus aureus infektionen

Info

Publication number
ATE335499T1
ATE335499T1 AT98964810T AT98964810T ATE335499T1 AT E335499 T1 ATE335499 T1 AT E335499T1 AT 98964810 T AT98964810 T AT 98964810T AT 98964810 T AT98964810 T AT 98964810T AT E335499 T1 ATE335499 T1 AT E335499T1
Authority
AT
Austria
Prior art keywords
compositions
treatment
staphylococcus aureus
aureus infections
infection
Prior art date
Application number
AT98964810T
Other languages
English (en)
Inventor
Naomi Balaban
James W Larrick
Susan C Wright
Original Assignee
Naomi Balaban
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naomi Balaban filed Critical Naomi Balaban
Application granted granted Critical
Publication of ATE335499T1 publication Critical patent/ATE335499T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98964810T 1997-12-19 1998-12-18 Zusammensetzungen zur behandlung von staphylococcus aureus infektionen ATE335499T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6809497P 1997-12-19 1997-12-19
US09/054,331 US6291431B1 (en) 1997-12-19 1998-04-02 Methods and compositions for the treatment and prevention of Staphylococcal infections

Publications (1)

Publication Number Publication Date
ATE335499T1 true ATE335499T1 (de) 2006-09-15

Family

ID=26732900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964810T ATE335499T1 (de) 1997-12-19 1998-12-18 Zusammensetzungen zur behandlung von staphylococcus aureus infektionen

Country Status (10)

Country Link
US (2) US6291431B1 (de)
EP (1) EP1037650B1 (de)
AT (1) ATE335499T1 (de)
AU (1) AU2005099A (de)
CY (1) CY1106234T1 (de)
DE (1) DE69835536T2 (de)
DK (1) DK1037650T3 (de)
ES (1) ES2270540T3 (de)
PT (1) PT1037650E (de)
WO (1) WO1999032133A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703374B1 (en) 1997-10-30 2004-03-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleosides for imaging and treatment applications
US7534857B2 (en) * 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
US7323179B2 (en) * 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US20080219976A1 (en) * 1997-12-19 2008-09-11 Naomi Balaban Methods and compositions for treatment and prevention of staphylococcal infections
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
EP1188831B1 (de) * 1998-09-15 2007-12-05 Naomi Balaban Ziel des RNAIII activierenden Proteines (TRAP)
EP1862549A3 (de) * 1998-09-15 2008-02-13 Naomi Balaban Target eines RNAIII-aktivierenden Proteins (TRAP)
AU2001238115A1 (en) * 2000-02-10 2001-08-20 Intermune, Inc. Novel amino acid and peptide inhibitors of staphylococcus virulence
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
CN1569889A (zh) * 2003-07-21 2005-01-26 中国人民解放军军事医学科学院基础医学研究所 能与金葡菌自分泌的rnaiii激活蛋白结合的环多肽及其医药用途
EP1621203A1 (de) * 2004-07-27 2006-02-01 Genoscience RNAIII-inhibierende Peptide für die Behandlung von HIV-Infektion
US20070015685A1 (en) * 2005-04-04 2007-01-18 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US20070009566A1 (en) * 2005-04-04 2007-01-11 Naomi Balaban Method and apparatus for treating bacterial infections in devices
US7824691B2 (en) * 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
US20070092572A1 (en) * 2005-04-04 2007-04-26 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
WO2006122127A1 (en) * 2005-05-10 2006-11-16 Naomi Balaban Compositions for administering rnaiii-inhibiting peptides
CA2630147C (en) 2005-11-18 2015-08-11 Glanbia Nutritionals (Ireland) Limited Compositions for disrupting and inhibiting reconstitution of wound biofilm
US20070248581A1 (en) * 2006-01-30 2007-10-25 The University Of Chicago Mgra is a redox regulator of antibiotic sensitivity and virulence
WO2007147098A2 (en) * 2006-06-16 2007-12-21 Tufts University Identification and use of non-peptide analogs of rnaiii-inhibiting peptide for the treatment of staphylococcal infections
JP2010524454A (ja) 2007-04-19 2010-07-22 モレキュラー ディテクション インコーポレーテッド 抗生物質耐性細菌の検出および分析のための方法、組成物、およびキット
WO2014013375A1 (en) 2012-07-16 2014-01-23 Pfizer Inc. Saccharides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3043362B2 (ja) 1989-04-27 2000-05-22 マクニール―ピーピーシー・インコーポレーテツド タンポンへの添加剤
WO1996010579A1 (en) 1994-10-04 1996-04-11 New York University Blocking expression of virulence factors in s. aureus
PT932613E (pt) 1996-05-22 2005-06-30 Univ New York Expressao de bloqueio de factoes de virulencia em s. aureus
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections

Also Published As

Publication number Publication date
DK1037650T3 (da) 2006-12-11
US6291431B1 (en) 2001-09-18
EP1037650B1 (de) 2006-08-09
EP1037650A4 (de) 2004-10-20
US20040077534A1 (en) 2004-04-22
ES2270540T3 (es) 2007-04-01
WO1999032133A1 (en) 1999-07-01
CY1106234T1 (el) 2011-06-08
DE69835536T2 (de) 2007-08-09
AU2005099A (en) 1999-07-12
EP1037650A1 (de) 2000-09-27
US7067135B2 (en) 2006-06-27
PT1037650E (pt) 2006-12-29
DE69835536D1 (de) 2006-09-21

Similar Documents

Publication Publication Date Title
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
ATE345115T1 (de) Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten
DE69925256D1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
PT920421E (pt) Derivados de isoxazolina uteis como agentes antimicrobianos
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
PT1077718E (pt) Melhoramentos da actividade de agentes antibacterianos de oxazolidinona por derivados de arginina
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
DE69825128D1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
ATE310088T1 (de) Behandlung und nachweis von staphylokokkeninfektionen
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
WO2004034961A3 (en) Antimicrobial agents and uses thereof
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
DE69716056D1 (de) Acylurea-verbindungen zur behandlung von coccidioidomycosis bei warmblütigen tieren
DE69935662D1 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
WO2004064784A3 (en) Composition and method for preventing or treating a virus infection
DE60134881D1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037650

Country of ref document: EP